Anixa Biosciences
ANIX
21 hedge funds and large institutions have $4.44M invested in Anixa Biosciences in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
11% more funds holding
Funds holding: 19 → 21 (+2)
0.89% more ownership
Funds ownership: 6.79% → 7.68% (+0.89%)
9% less capital invested
Capital invested by funds: $4.89M → $4.44M (-$448K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$284K |
| 2 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
+$137K |
| 3 |
Two Sigma Investments
New York
|
+$102K |
| 4 |
Two Sigma Advisers
New York
|
+$93.7K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$79.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$120K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41.8K |
| 3 |
Morgan Stanley
New York
|
-$28.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.66K |
| 5 |
BlackRock
New York
|
-$3.1K |
ANIX Hedge Fund Activity: Q3 2020 in Review
21 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2020, worth a combined $4.44M — down 9.2% from $4.89M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ANIX positions and 4 closed out — a net gain of 2 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Qube Research & Technologies (QRT), adding an estimated $284K. The largest seller was Millennium Management, exiting entirely with an estimated $120K sold.
- 21 institutional investors held Anixa Biosciences (ANIX) as of Q3 2020, up from 19 in Q2 2020.
- Funds reported $4.44M of Anixa Biosciences stock for Q3 2020, down 9.2% quarter-over-quarter.
- 6 funds opened new Anixa Biosciences positions in Q3 2020 and 4 closed out, a net change of +2 holders.
- The largest Anixa Biosciences buyer in Q3 2020 was Qube Research & Technologies (QRT), an estimated $284K added.
- The largest Anixa Biosciences seller in Q3 2020 was Millennium Management, an estimated $120K sold.
Based on aggregated 13F filings for Q3 2020.